Adam S. Mostafa, Chief Financial Officer at X4 Pharmaceuticals, Inc (XFOR), sold 27,721 shares at $0.93 ($26K) on 2023-02-13, disclosed to the SEC on 2023-02-15.
Scheduled sale ($26k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| XFOR | SELL | 2024-03-11 | $46K | — | Filing → |
| XFOR | SELL | 2024-02-12 | $28K | — | Filing → |
| XFOR | SELL | 2023-11-03 | $337K | — | Filing → |